Filter News
Area of Research
- (-) Neutron Science (3)
- Advanced Manufacturing (1)
- Biology and Environment (21)
- Computational Biology (2)
- Computational Engineering (1)
- Computer Science (3)
- Electricity and Smart Grid (1)
- Energy Science (14)
- Functional Materials for Energy (1)
- Fusion and Fission (2)
- Materials (8)
- National Security (23)
- Nuclear Science and Technology (1)
- Quantum information Science (2)
- Supercomputing (51)
News Topics
- (-) Cybersecurity (1)
- (-) High-Performance Computing (2)
- 3-D Printing/Advanced Manufacturing (6)
- Advanced Reactors (1)
- Artificial Intelligence (6)
- Big Data (2)
- Bioenergy (7)
- Biology (7)
- Biomedical (14)
- Biotechnology (1)
- Chemical Sciences (3)
- Clean Water (2)
- Composites (1)
- Computer Science (13)
- Coronavirus (10)
- Energy Storage (6)
- Environment (8)
- Fossil Energy (1)
- Frontier (1)
- Fusion (1)
- Hydropower (1)
- Machine Learning (3)
- Materials (14)
- Materials Science (23)
- Mathematics (1)
- Microscopy (3)
- Nanotechnology (10)
- National Security (2)
- Neutron Science (120)
- Nuclear Energy (3)
- Physics (9)
- Polymers (1)
- Quantum Computing (1)
- Quantum Science (7)
- Security (2)
- Space Exploration (3)
- Summit (6)
- Transportation (5)
ORNL's Communications team works with news media seeking information about the laboratory. Media may use the resources listed below or send questions to news@ornl.gov.
1 - 3 of 3 Results

The Department of Energy’s Office of Science has selected three ORNL research teams to receive funding through DOE’s new Biopreparedness Research Virtual Environment initiative.

Three ORNL scientists have been elected fellows of the American Association for the Advancement of Science, or AAAS, the world’s largest general scientific society and publisher of the Science family of journals.

An ORNL-led team comprising researchers from multiple DOE national laboratories is using artificial intelligence and computational screening techniques – in combination with experimental validation – to identify and design five promising drug therapy approaches to target the SARS-CoV-2 virus.